22 Comments
User's avatar
alan flashman's avatar

Note from a dinosaur. A very moving and very timely rant. Child and adolescent mental health is indeed in a crisis. I completed 6 years of residency - peds. psych' child psych - in1981. Some of us then thought that adolescent psychiatry - that's the focus of your rant - was part of a community program to health teens get throught the rocky hormonal social and familal landscape recently lableled as adolescence. There was hope that a local program coordianted with school mental health personnel, family therapists, all other therapists and child psychiatrists could prove effective one community at a time. I even chhose to move to the remote Negev in Israel to start such a program. It was dead in 18 months, but I am still there doing what I can.

Yours is a totally different world. I see from the responses a desparate wish to believe that biology will solve everything. It WILL NOT. People need people who understand them, adolescents need adults around them who remember their own adolescence, and some herbs or medicines for some. Fist become a whole human professional, learn everything you can about personal and family development. Make a healing plan to which a sunstance could be part, never all. Learn about CBD and St John's Wort.

You will not be compensated externally for these efforts. BigPharma has acquired our profession lack stock and barrel. All CMEs all conferences, and publications, all research. But when that 15 year old in distress come to you, You are her world, she needs to see a better version of herself in YOUR eyes (once called the working model of the patient by Maralyn Monroe's psychiatrist). The conference that is driving you mad won't offer that. Reach out to other kindred spirits I am sure you are not alone. The first time that you delay printing that presciption that our entire medical callosus expects asap and ask that girl (or ask yourself) "Do you feel I have undertsood you?" what you will see in her eyes will be your firts step to freedom. YOU decide what kind of doctor you are offereing to your patient.

I guess this was also sort of a rant, but rant for rant. Yours gave me hope. Good luck

Owen Scott Muir, M.D.'s avatar

As someone who's been treated with TMS personally a bunch, I know how unsettling it can be, and how important careful titration is to helping make it tolerable.

Adam Coles, MD's avatar

Universities and industry seem to have largely ignored (or suppressed if I'm being paranoid) in their practices the big Cochrane review from 2021 that found declining efficacy of all SSRI's compared to previous reviews / studies. Personally I'm prescribing less and less, and then only if the clinical presentation matches a responsive picture from prior clients. It's imperfect but I get more response and fewer side effects. Add to that dosing actually at a treatment level with therapy and a much higher remission rate results, followed by tapering off instead of existing for years on a medication.

Part of the problem lies in the fact that we're being challenged to find clinical treatment for things that are often at least affected by if not worsened/caused by cultural, environmental and sociological stressors that remain unaddressed. Until we improve the social determinants of (mental and physical) health and make our culture less isolative, destructive and stressful, we'll be up against it in our business.

I'm switching jobs to a shift-based Psych ER setting, where I'll see plenty of kids still (and boarding is a problem I hope to address once I'm there), for a number of reasons, but the shift-based work fits my needs better now. I'm also having a lot of moral and bureaucratic fatigue with the health system I'm in.

Owen Scott Muir, M.D.'s avatar

I would challenge you to think about the fact that there is an increasing effect size in TMS and other neuromodulatory treatment trials over the years, which is in the context of the background trend in reduced effect size. Thus, maybe we're using the wrong treatments, and blaming the lack of response on psychosocial trends where we feel powerless to change things?

Adam Coles, MD's avatar

There may be increasing effect size of TMS and other neuromodulatory treatments, however I would challenge you to think about two things:

1) the fact that we should be practicing primary and secondary prevention before treating things once they're full blown, and

2) It's well described that the social determinants of health especially among those without access to high-end insurance have been worsening, and of course, we don't have access on Maui to research-based treatments. I'm personally interested in NM treatments and I appreciate your enthusiasm for the area, but we need to be looking at the whole picture.

YoginiMD's avatar

What are your thoughts on ketamine treatment in this age group?

Owen Scott Muir, M.D.'s avatar

We are likely to have topline data from Janssen soon, but as I said, it's not like any of the drugs that are oral are effective, and the safety profile is likely favorable. There are not enough guard rails around off label IV ketamine at scale for me, that haven't been said, we've been giving ketamine to children for anesthesia for many years, without much of a fuss

YoginiMD's avatar

Agreed. I’ve been convening a group of practitioners for two years now developing best practices in the various settings — ER, outpatient, IOP — and we have some clinical expertise building slowly but surely: for example the developmental lens we can apply is important, plus masked autism is a hidden population within this cohort that must be addressed in markedly different ways.

We would love to invite a conversation with our community to parse through some of these nuances. Would love to connect the network of interested providers more to advance this knowledge so we can be ready with harm reduction and sound guidelines for this age group. What do you think is the timeline for when this may become available for adolescents and young adults?

Our website is in development and we hope to have a directory of practitioners page and membership soon. www.ayakap.org

Appreciate your thoughts.

Suraiya

S. Rudd's avatar

What about for depression comorbidity like anxiety? Scott Alexander has argued antidepressants are better for anxiety disorders as they have bigger effect sizes.

Owen Scott Muir, M.D.'s avatar

Scott is a great writer--but being "better for anxiety disorders" is not what they are labeled for, and GAD is notoriously hard to study, because the placebo response is so large. I think this is a fair thought, but also, kind of like arguing which is the "biggest ant"...when you are among elephants.

Sheila's avatar

You’re right about SAINT (accelerated TMS) showing promise.

Poems from Your Mother's avatar

Thank you for this article, we need better options that are accessible to teens and their families. Badly.

Owen Scott Muir, M.D.'s avatar

I've been working on those better options since 2017, and I'm happy to see some of them getting over the line FDA labels! The next step is insurance coverage, and broad awareness, but please, tell everyone in your life that brain stimulation, like transcranial magnetic stimulation, exists, and has evidence to treat youth. Therapy works too, and all of it has better evidence for safety and efficacy than most medicines.

Poems from Your Mother's avatar

I’m beating the drum, I practice CAP and just got a TMS machine in office.

L Thompson's avatar

I would like to comment on one aspect of this very needed "rant" with my own "rant" (we need more ranting on this issue!). One could assume that suicide attempts are more prevalent in girls (13%) verses (7%) for boys. But the undeniable fact is that boys consistently die of suicide at a 4:1 rate with girls. A study on suicide attempt profiles of living male and female cohorts, most obviously does not include those already dead from suicide. It is a morbid truism that while most girls go to the ER following a suicide attempt, to be counted in our statistical analysis, most boys are going directly to the morgue. Meanwhile, we continue to talk of the female disparity of suicidal depression, along with funding and public outcry, while the boys are dead and ignored. We need to be precise in our reporting: when we talk of the comparative female to male rates of suicide attempts we need to state the obvious, but ignored, fact that our study population is unsuccessful suicide attempts that present to the ER and not the total suicide attempts including successful attempts! When we are studying the comparative female to male rates of depression, we need to say that it is the detected rates of depression.

Bottom line:

1) We are deliberately confounding our suicide statistics by excluding the vast number of successful male suicides, and only counting the few males suicides that aren't successful, and building a false narrative around that to favor resources to be channeled to the female "disparity."

2) We are undercounting male depression, because our survey tools favor female expressions of depression, and under detect male depression.

3) We need to increase spending on teen male suicide specifically to address the 4:1 risk of actual death to suicide for male teens!

David Behar's avatar

The idea that “nothing works” for adolescent depression often reflects misdiagnosis. Major depression usually begins around age 39, so when it appears in early adolescence, clinicians should strongly consider early-onset bipolar disorder. Antidepressants can actually worsen bipolar depression by causing agitation or mixed states. A one-minute family history is critical: if any first- or second-degree relative has shown signs of mania or hypomania, the safer course is a mood stabilizer such as lithium, valproate, or aripiprazole. Evidence shows that many ‘treatment-resistant’ depressed adolescents actually have unrecognized bipolar-spectrum illness, and outcomes improve significantly when they receive appropriate mood-stabilizing treatment instead of antidepressants. The young onset age implies a heavy genetic loading, and a course of worsening with age. Therefore treatment should continue the rest of life, except for pregnancy.

Olga M's avatar

Thank you for your very important comment, showing knowledge and expertise. It's sadly so rare in real life practice. One of the problem is that patients see (and rightfully so) the diagnosis of depression as less stigmatizing than bipolar disorder (manic-depressive psychosis!) and may willingly or not hide the important facts of family history. As a result, many misdiagnosed adolescents are given SSRIs which at best do not work and at worst may push a young person over the edge.

As to TMS mentioned in other comments: I would really recommend the proponents to try a session or two on themselves to appreciate how traumatizing this treatment is.

Aussie Med Student's avatar

I wonder whether you mean to equate suicidality with depression? Here adjustment disorder accounts for a lot of suicidality and attempts especially in young people. And nobody is recommending meds for adjustment disorder. (Except the family doctor who often gets to them first and mislabels them as depressed.)

Owen Scott Muir, M.D.'s avatar

I'm not speaking to that cohort. I'm addressing depression with co-occurring si generally. Adjustment disorder is addressable with psychotherapy which should be first line in all disorders of childhood.

Poems from Your Mother's avatar

I think TMS in adolescents especially accelerated protocols are going to be very important in the future, thank you for shedding light on this